Clinical Trial

Study of Tacrolimus Melt-Dose® for Lung Transplant Patients

Name: Study of Tacrolimus Melt-Dose® for Lung Transplant Patients — clinical trial record (NCT07042035)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ESENCIAL

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate, under usual clinical practice conditions and with a 12-month follow-up , the most relevant pharmacokinetic parameters of tacrolimus metabolism and safety, in patients with recent lung transplant (unilateral or bilateral) treated with LCPT.

Trial Details

NCT Number	NCT07042035
Lead Sponsor	Chiesi España, S.A.U. Collaborators: Trialance SCCL
Conditions	Lung Trasplant, Lung Transplantation
Enrollment	240 participants
Start Date	2024-10-29
Primary Completion	2026-10-29 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-27